North America Genomics Market Growth Drivers and Forecast by 2027

North America Genomics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology (Sequencing, Microarray, Polymerase chain reaction (PCR), Nucleic Acid Extraction and Purification, and Others), Product & Service (Instruments/Systems, Consumables, and Services), Application (Diagnostics, Drug Discovery and Development, Precision/Personalized Medicine, Agriculture & Animal Research, and Others), End User (Research Centers, Hospitals and Clinics, Pharmaceutical & Biotechnology Companies, and Others), and Country

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027
  • Status : Published
  • Report Code : TIPRE00004301
  • Category : Life Sciences
  • No. of Pages : 234
  • Available Report Formats : pdf-format excel-format
Buy Now
North America Genomics Market Growth Drivers and Forecast by 2027
Report Date: Mar 2021   |   Report Code: TIPRE00004301 Email: sales@theinsightpartners.com
Buy Now

The North America Genomics market is expected to reach US$ 20,348.43 million in 2027 from US$ 7,669.34 million in 2019. The market is estimated to grow with a CAGR of 13.3% from 2020-2027.

Genomics is defined as the study of a gene and its functioning. Genomics is used to examine the molecular mechanisms and the interaction of genetic and environmental factors in the diseases. The major factors attributing to the growth of the genomics market are growing government support and increased number of genomics studies, declining sequencing cost, increased genomics applications. The scope of the genomics market includes technology, product and service, application, end-user, and region.

US Genomics Market Revenue and Forecasts to 2027 (US$ MN)

US Genomics Market Revenue and Forecasts to 2027 (US$ MN)

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

NORTH AMERICA GENOMICS MARKET SEGMENTATION

By Technology

  • Sequencing
  • Microarray
  • Polymerase Chain Reaction
  • Nucleic Acid Extraction and Purification
  • Others

By Product and Services

  • Instruments/Systems
  • Consumables
  • Services

By Application

  • Diagnostics
  • Drug Discovery and Development
  • Precision/Personalized Medicine
  • Agriculture & Animal Research
  • Others

By End User

  • Research Centers
  • Hospitals & Clinics
  • Biotechnology & Pharmaceutical Companies
  • Others

By Country

  • North America
    • US
    • Canada
    • Mexico

Company Profiles

  • Illumina, Inc.
  • Danaher
  • F. HOFFMANN-LA ROCHE LTD.
  • BIO-RAD LABORATORIES INC.
  • General Electric Company
  • THERMO FISHER SCIENTIFIC INC.
  • Agilent Technologies, Inc.
  • Eurofins Scientific
  • QIAGEN
  • BGI

North America Genomics Report Scope

Report Attribute Details
Market size in 2019 US$ 7,669.34 Million
Market Size by 2027 US$ 20,348.43 Million
CAGR (2020 - 2027) 13.3%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Technology
  • Sequencing
  • Microarray
  • Polymerase chain reaction
  • Nucleic Acid Extraction and Purification
By Product & Service
  • Instruments/Systems
  • Consumables
  • Services
By Application
  • Diagnostics
  • Drug Discovery and Development
  • Precision/Personalized Medicine
  • Agriculture & Animal Research
By End User
  • Research Centers
  • Hospitals and Clinics
  • Pharmaceutical & Biotechnology Companies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • Illumina, Inc.
  • Danaher
  • F. HOFFMANN-LA ROCHE LTD.
  • BIO-RAD LABORATORIES INC.
  • General Electric Company
  • THERMO FISHER SCIENTIFIC INC.
  • Agilent Technologies, Inc.
  • Eurofins Scientific
  • QIAGEN
  • BGI
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
☀️ Eligible for Summer Discount
Unlock Exclusive Report Discounts
Enquire Now
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA
Page Updated: Mar 2021